AJG Stock: Buy or Sell? Price Target & Forecast

AJG Arthur J. Gallagher & Co. As of Jul 8, 2026

$254.67

Insurance broker consolidator: valuation stretched, but M&A momentum + analyst upgrades support near-term holding. Defensive positioning with modest growth premium.

Setup: Growth + M&A consolidation play Confidence: 68 Horizon: 3–6 months Risk: Medium Category: Large Cap

🔒 Trade Plan — entry · target · stop

Entry Zone

$•••–•••

Target

$•••

Stop Loss

$•••

Risk / Reward

•.• : 1

Unlock the exact levels — free →

A free account reveals AJG's entry zone, price target & stop loss. Full 1-week to 1-year price forecasts are included with Pro.

The Thesis

▲ Bull Case

17.7% YoY revenue growth + active M&A (Wilson M. Beck acquisition just announced) positions AJG as insurance sector consolidator. Barclays raised PT to $292 (+14.7% upside); Morgan Stanley at $255 (near-parity). Defensive business model + 1.1% dividend yield + 44.7% payout ratio provide stability. Insider net-buying trend (99 buys vs 94 sells, 1.49M net shares) signals conviction. Operating margin 18.3% and gross margin 46.1% show pricing power.

▼ Bear Case

Valuation demanding: P/E 40.7x, forward 43.9x, P/S 4.7x, price-to-FCF 36.8x all stretch relative to 3.4% current EPS growth (though 5-yr 6.5% supports quality premium). Stock down 20% from 52-week high of $318.34; still 33.6% above 52-week low. Current ratio 1.06 tight; no debt-to-equity data. Beta 0.51 reflects low volatility, but also capped upside. M&A tail risk if deals destroy value.

Valuation

overvalued on absolute multiples; fair on growth-adjusted basis — score 58/100

P/E 40.7x, forward 43.9x, P/S 4.7x, price-to-FCF 36.8x all stretch absolute valuations. However, 17.7% YoY revenue growth + 6.5% 5-yr EPS growth + 46% gross margin + 18.3% op margin justify premium to market (S&P 500 ~18x P/E). PEG unavailable; estimated PEG ~1.8–2.0x (moderate premium given quality). Book value $90.74 vs price $254.67 (P/B 2.85x) reflects intangible asset premium (brand, scale, data). Insider buying (net +1.49M shares) suggests management sees fair value upside.

Technical Levels

Support · $245.00 (Recent consolidation low; 1-mo moving average approx) · $235.00 (Key psychological level; ~7.7% downside from current) · $220.00 (Approximate 6-mo moving average; major support if broken)

Resistance · $265.00 (Intraday high (256.63); short-term friction) · $292.00 (Barclays price target; major institutional resistance) · $318.00 (52-week high; psychological ceiling)

RSI: not provided

Financial Health

Score 71/100. Balance sheet appears stable: current & quick ratios 1.06x adequate for insurance broker. Book value $90.74/share solid; tangible BV $49.17/share suggests strong intangible asset base (client lists, brand, goodwill). Dividend yield 1.1% + payout ratio 44.7% conservative; room to raise or maintain through cycles. CAVEAT: no debt-to-equity or interest coverage provided; cannot fully assess leverage or debt service capacity. M&A activity (Wilson M. Beck) may involve debt financing — warrant monitoring of balance sheet post-deal.

Risk Flags

Valuation premium (P/E 40.7x) leaves little margin for error; earnings miss could trigger sharp pullback.

M&A integration risk; undisclosed deal terms for Wilson M. Beck warrant monitoring for accretion.

52-week high retreat (−20%) may indicate sentiment shift; near-term support at 245–250 critical.

See AJG's full trade plan — free

Create a free account to unlock the exact entry, target, and stop — plus run live analysis on any of 5,000+ tickers. No card required.

Unlock AJG free →

More Analyses

AAPL

AMZN

GOOGL

NFLX

AVGO

Micron Technology Inc

AJG FAQ

Is AJG a buy right now?

Arthur J. Gallagher & Co.'s current read is a Growth + M&A consolidation play setup with 68 confidence over a 3–6 months horizon. Valuation: overvalued on absolute multiples; fair on growth-adjusted basis. See the full bull and bear case above, or run a live analysis for the exact entry, target and stop.

Is AJG overvalued?

overvalued on absolute multiples; fair on growth-adjusted basis (valuation score 58/100). P/E 40.7x, forward 43.9x, P/S 4.7x, price-to-FCF 36.8x all stretch absolute valuations. However, 17.7% YoY revenue growth + 6.5% 5-yr EPS growth + 46% gross margin + 18.3% op margin justify premium to market (S&P 500 ~18x P/E). PEG unavailable; estimated PEG ~1.8–2.0x (moderate premium given quality). Book value $90.74 vs price $254.67 (P/B 2.85x) reflects intangible asset premium (brand, scale, data). Insider buying (net +1.49M shares) suggests management sees fair value upside.

What are the risks of buying AJG?